feed,title,long_url,short_url
Benzinga,Analysts Lower Price Targets On Snap After Q3 Performance,https://benzinga.com/news/21/10/23502471/analysts-lower-price-targets-on-snap-after-q3-performance,https://j.mp/3C6ax3D
Benzinga,"The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs",https://benzinga.com/general/biotech/21/10/23503884/the-daily-biotech-pulse-athira-ceo-resigns-over-doctored-research-mercks-keytruda-snags-first-app,https://j.mp/2Z9ztbO
